Study finds cirrhosis affects twice as many transgender adults as cisgender adults

byUniversity of Southern CaliforniaCredit:American Journal of Gastroenterology(2024). DOI: 10.14309/ajg.0000000000002907Cirrhosis is chronic, progressive end-stage liver disease that

Updated on: July 11,2024

Study finds cirrhosis affects twice as many transgender adults as cisgender adults

byUniversity of Southern CaliforniaCredit:American Journal of Gastroenterology(2024). DOI: 10.14309/ajg.0000000000002907Cirrhosis is chronic, progressive end-stage liver disease that

Updated on:July 11,2024

Hepatitis B: 'Sleep timer' for immune cells discovered

byTechnical University MunichA virus-specific T cell (blue) in the vascular system of a liver with chronic hepatitis B virus infection. Credit: Percy A. Knolle / TUMIn chronic hepatitis B, the l

Updated on: July 15,2024

Hepatitis B: 'Sleep timer' for immune cells discovered

byTechnical University MunichA virus-specific T cell (blue) in the vascular system of a liver with chronic hepatitis B virus infection. Credit: Percy A. Knolle / TUMIn chronic hepatitis B, the l

Updated on:July 15,2024

Detection of minimal hepatic encephalopathy in patients with cirrhosis based on the Stroop-CN model

by Sichuan International Medical Exchange and Promotion AssociationPrevalence of minimal hepatic encephalopathy (MHE) in different groups of patients with cirrhosis. Credit:MedComm(2024).

Updated on: August 01,2024

Detection of minimal hepatic encephalopathy in patients with cirrhosis based on the Stroop-CN model

by Sichuan International Medical Exchange and Promotion AssociationPrevalence of minimal hepatic encephalopathy (MHE) in different groups of patients with cirrhosis. Credit:MedComm(2024).

Updated on:August 01,2024

Universal gut microbiome-derived signature predicts cirrhosis

by University of California - San DiegoIllustration depicts a healthy liver (left) and a liver with cirrhosis. Credit: National Institute of Diabetes and Digestive and Kidney DiseasesNonalcoholic

Updated on: May 28,2024

Universal gut microbiome-derived signature predicts cirrhosis

by University of California - San DiegoIllustration depicts a healthy liver (left) and a liver with cirrhosis. Credit: National Institute of Diabetes and Digestive and Kidney DiseasesNonalcoholic

Updated on:May 28,2024

Alcoholic pancreatitis patients with continued alcohol intake may finally have therapeutic options

by University of MiamiGraphical abstract. Credit:American Journal of Physiology-Gastrointestinal and Liver Physiology(2022). DOI: 10.1152/ajpgi.00159.2022Many alcoholic pancreatitis p

Updated on: July 04,2024

Alcoholic pancreatitis patients with continued alcohol intake may finally have therapeutic options

by University of MiamiGraphical abstract. Credit:American Journal of Physiology-Gastrointestinal and Liver Physiology(2022). DOI: 10.1152/ajpgi.00159.2022Many alcoholic pancreatitis p

Updated on:July 04,2024

Acute pancreatitis may progress to chronic with sustained heavy alcohol use

by Lori SolomonMany patients with recurrent acute pancreatitis (RAP) and acute pancreatitis (AP) have high lifetime cumulative drinking and heavy daily alcohol use, suggesting disease progression towa

Updated on: June 12,2024

Acute pancreatitis may progress to chronic with sustained heavy alcohol use

by Lori SolomonMany patients with recurrent acute pancreatitis (RAP) and acute pancreatitis (AP) have high lifetime cumulative drinking and heavy daily alcohol use, suggesting disease progression towa

Updated on:June 12,2024

Finding new targets for blocking chronic hepatitis

byTokyo Medical and Dental UniversityLoss of A20 function in hepatic stellate cells upregulated the DCLK1-JNK phosphorylation axis. DCLK1 enhances chemokine expression, leading to progression of

Updated on: September 10,2024

Finding new targets for blocking chronic hepatitis

byTokyo Medical and Dental UniversityLoss of A20 function in hepatic stellate cells upregulated the DCLK1-JNK phosphorylation axis. DCLK1 enhances chemokine expression, leading to progression of

Updated on:September 10,2024

CDC: Prevalence of any past, present hep B infection 4.3 percent

(HealthDay)—The prevalence of any past or present hepatitis B virus (HBV) infection was 4.3 percent among U.S. adults during 2015 to 2018, according to a March data brief published by the U.S. Centers

Updated on: June 12,2024

CDC: Prevalence of any past, present hep B infection 4.3 percent

(HealthDay)—The prevalence of any past or present hepatitis B virus (HBV) infection was 4.3 percent among U.S. adults during 2015 to 2018, according to a March data brief published by the U.S. Centers

Updated on:June 12,2024

Acute pancreatitis and the rise of alcohol-related deaths

by Deb Balzer,Mayo ClinicEndoscopic retrograde cholangiopancreatography (ERCP) uses a dye to highlight the bile ducts and pancreatic duct on X-ray images. A thin, flexible tube (endoscope) with

Updated on: June 12,2024

Acute pancreatitis and the rise of alcohol-related deaths

by Deb Balzer,Mayo ClinicEndoscopic retrograde cholangiopancreatography (ERCP) uses a dye to highlight the bile ducts and pancreatic duct on X-ray images. A thin, flexible tube (endoscope) with

Updated on:June 12,2024

'Treat-all' strategy for patients with chronic hepatitis B virus infection in China: Are we there yet?

by Xia & He Publishing Inc.Graphical Abstract. Credit:Journal of Clinical and Translational Hepatology(2024). DOI: 10.14218/JCTH.2024.00091Chronic hepatitis B (CHB) remains a significa

Updated on: August 06,2024

'Treat-all' strategy for patients with chronic hepatitis B virus infection in China: Are we there yet?

by Xia & He Publishing Inc.Graphical Abstract. Credit:Journal of Clinical and Translational Hepatology(2024). DOI: 10.14218/JCTH.2024.00091Chronic hepatitis B (CHB) remains a significa

Updated on:August 06,2024

Popular diabetes drug may also reduce the risk of severe liver disease

by Karolinska InstitutetCredit: Pixabay/CC0 Public DomainOzempic and other GLP1 agonists are associated with a reduced risk of developing cirrhosis and liver cancer in people with type 2 diabetes

Updated on: June 01,2024

Popular diabetes drug may also reduce the risk of severe liver disease

by Karolinska InstitutetCredit: Pixabay/CC0 Public DomainOzempic and other GLP1 agonists are associated with a reduced risk of developing cirrhosis and liver cancer in people with type 2 diabetes

Updated on:June 01,2024

Protein controlling magnesium identified as therapeutic target for non-alcoholic fatty liver disease

by New York UniversityThe study identified the CNNM4 protein as a key regulator of magnesium (Mg) in the liver and potential therapeutic target for non-alcoholic fatty liver disease (NASH). Credi

Updated on: June 28,2024

Protein controlling magnesium identified as therapeutic target for non-alcoholic fatty liver disease

by New York UniversityThe study identified the CNNM4 protein as a key regulator of magnesium (Mg) in the liver and potential therapeutic target for non-alcoholic fatty liver disease (NASH). Credi

Updated on:June 28,2024